Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

7.0K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
7.0K
Metastasis02:30

Metastasis

3.9K
3.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

8.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.2K
3.2K
Tumor Progression02:07

Tumor Progression

8.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrasound-guided skeletal muscle biopsy technique permits measurement of structural, functional, cellular and biochemical properties.

Scientific reports·2026
Same author

Ultrasound-guided skeletal muscle biopsy technique permits measurement of structural, functional, cellular and biochemical properties.

medRxiv : the preprint server for health sciences·2026
Same author

Wild bonobos experience unusually low bone resorption during early lactation relative to humans and other mammals.

Evolutionary human sciences·2025
Same author

Six-Minute Walk Test Is Superior to Grip Strength as a Marker of Functional Recovery During Cancer Cachexia Rehabilitation.

Journal of cachexia, sarcopenia and muscle·2025
Same author

Addressing missing context in regulatory variation across primate evolution.

Current opinion in genetics & development·2025
Same author

Physiology of Cardiac Arrest with del Nido Cardioplegia.

Translational perioperative and pain medicine·2025

Related Experiment Video

Updated: Apr 15, 2026

Primary Tumor and MEF Cell Isolation to Study Lung Metastasis
06:31

Primary Tumor and MEF Cell Isolation to Study Lung Metastasis

Published on: May 20, 2015

16.7K

EMT and tumor metastasis.

Sarah Heerboth1, Genevieve Housman2, Meghan Leary1

  • 1Cancer Center, Department of Medicine, Boston University School of Medicine, Boston, MA USA.

Clinical and Translational Medicine
|April 9, 2015
PubMed
Summary

Epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) are key cellular processes in development and cancer. Reversible epigenetic events are hypothesized to regulate these transitions and metastatic cancer development.

More Related Videos

Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells
08:54

Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells

Published on: May 20, 2020

10.4K
Induction and Analysis of Epithelial to Mesenchymal Transition
10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

36.8K

Related Experiment Videos

Last Updated: Apr 15, 2026

Primary Tumor and MEF Cell Isolation to Study Lung Metastasis
06:31

Primary Tumor and MEF Cell Isolation to Study Lung Metastasis

Published on: May 20, 2015

16.7K
Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells
08:54

Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells

Published on: May 20, 2020

10.4K
Induction and Analysis of Epithelial to Mesenchymal Transition
10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

36.8K

Area of Science:

  • Cellular biology
  • Developmental biology
  • Cancer research

Background:

  • Epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) are fundamental cellular processes.
  • These transitions are crucial for normal development and cancer metastasis.

Purpose of the Study:

  • To review EMT and MET processes and their molecular pathways.
  • To compare these processes in embryogenesis and cancer metastasis.
  • To discuss the clinical implications and epigenetic regulation of EMT/MET.

Main Methods:

  • Comparative analysis of embryogenesis and cancer metastasis.
  • Discussion of signaling pathways and receptor expression.
  • Exploration of epigenetic mechanisms.

Main Results:

  • EMT and MET involve complex molecular pathways and receptor dynamics.
  • Clinical implications of EMT/MET are observed across various tumor types.
  • Epigenetic events play a significant role in regulating EMT/MET.

Conclusions:

  • EMT and MET are integral to both development and cancer.
  • Reversible epigenetic events are hypothesized to control EMT/MET and metastatic cancer progression.